2023 Q1 Form 10-K Financial Statement

#000164033423001477 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2023 2022 Q1
Revenue $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $88.49K
YoY Change -5.07%
Operating Profit -$88.49K
YoY Change -5.07%
Interest Expense $32.24K
YoY Change 4.95%
% of Operating Profit
Other Income/Expense, Net -$89.04K
YoY Change 234.44%
Pretax Income
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$177.5K
YoY Change 48.14%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2023 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.640K
YoY Change
Cash & Equivalents $7.644K $8.208K
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change
Inventory
Prepaid Expenses $0.00 $3.800K
Receivables $0.00 $0.00
Other Receivables $9.260K
Total Short-Term Assets $16.91K $16.91K $22.95K
YoY Change -26.32%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $3.168K $0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $3.167K $3.160K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $16.91K $16.91K $22.95K
Total Long-Term Assets $3.167K $3.160K $0.00
Total Assets $20.07K $20.07K $22.95K
YoY Change -12.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $219.9K
YoY Change
Accrued Expenses $264.5K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $1.223M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.707M $1.707M $1.662M
YoY Change 2.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.707M $1.707M $1.662M
Total Long-Term Liabilities $0.00
Total Liabilities $1.707M $1.707M $1.662M
YoY Change 2.71%
SHAREHOLDERS EQUITY
Retained Earnings -$7.962M -$7.784M
YoY Change 2.28%
Common Stock $67.95K $67.95K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.687M -$1.687M -$1.639M
YoY Change
Total Liabilities & Shareholders Equity $20.07K $20.07K $22.95K
YoY Change -12.52%

Cashflow Statement

Concept 2023 Q1 2023 2022 Q1
OPERATING ACTIVITIES
Net Income -$177.5K
YoY Change 48.14%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$54.89K
YoY Change 127.41%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $22.63K
YoY Change -50.06%
NET CHANGE
Cash From Operating Activities -$54.89K
Cash From Investing Activities
Cash From Financing Activities $22.63K
Net Change In Cash -$565.00
YoY Change -106.88%
FREE CASH FLOW
Cash From Operating Activities -$54.89K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Assets
Assets
20074 usd
CY2022Q1 us-gaap Assets
Assets
22948 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
219896 usd
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
225243 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
264482 usd
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
233064 usd
CY2023Q1 us-gaap Notes Payable
NotesPayable
544812 usd
CY2022Q1 us-gaap Notes Payable
NotesPayable
529344 usd
CY2023Q1 ptos Related Party Current Liabilities
RelatedPartyCurrentLiabilities
677962 usd
CY2022Q1 ptos Related Party Current Liabilities
RelatedPartyCurrentLiabilities
674426 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
67947 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
67947 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6542783 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6542783 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7961863 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7784335 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-335944 usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001172069
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67946513 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67946513 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67946513 shares
CY2022 ptos Increase Decrease In Bank Indebtedness
IncreaseDecreaseInBankIndebtedness
20 usd
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1639129 usd
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
333-91190
CY2023 dei Entity Registrant Name
EntityRegistrantName
P2 SOLAR, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0234680
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
13718 91 Avenue
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Surrey
CY2023 dei Entity Address Country
EntityAddressCountry
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V3V 7X1
CY2023 dei City Area Code
CityAreaCode
778
CY2023 dei Local Phone Number
LocalPhoneNumber
321-0047
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Public Float
EntityPublicFloat
158286 usd
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
67946513 shares
CY2023 dei Auditor Name
AuditorName
Gries & Associates LLC
CY2023 dei Auditor Location
AuditorLocation
Denver, Colorado
CY2023 dei Auditor Firm
AuditorFirmId
6778
CY2023Q1 us-gaap Other Receivables
OtherReceivables
9263 usd
CY2022Q1 us-gaap Other Receivables
OtherReceivables
10940 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 usd
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3800 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
16907 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
22948 usd
CY2023Q1 us-gaap Goodwill
Goodwill
3168 usd
CY2022Q1 us-gaap Goodwill
Goodwill
0 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1707152 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1662077 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1707152 usd
CY2022Q1 us-gaap Liabilities
Liabilities
1662077 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67946513 shares
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-465524 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1687078 usd
CY2023 us-gaap Revenues
Revenues
0 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20074 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22948 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
30151 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
29663 usd
CY2023 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
56600 usd
CY2022 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
59734 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
88487 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
93214 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-88487 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-93214 usd
CY2023 us-gaap Interest Expense
InterestExpense
32237 usd
CY2022 us-gaap Interest Expense
InterestExpense
30716 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-56805 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4092 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-89041 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-26624 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-177528 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-119838 usd
CY2023 ptos Net Profit Loss
NetProfitLoss
-177528 usd
CY2022 ptos Net Profit Loss
NetProfitLoss
-119838 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
129580 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-11209 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-47948 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-131047 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1484186 usd
CY2022 ptos Stock Cancellationd During Period Shares Other
StockCancellationdDuringPeriodSharesOther
-23897 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-11209 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-119838 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1639129 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
129580 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-177528 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1687078 usd
CY2023 us-gaap Profit Loss
ProfitLoss
177528 usd
CY2022 us-gaap Profit Loss
ProfitLoss
119837 usd
CY2023 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
141 usd
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
25 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3589 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3788 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
12185 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10358 usd
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
50407 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
29442 usd
CY2023 ptos Increase Decrease In Management Fees Payables
IncreaseDecreaseInManagementFeesPayables
56600 usd
CY2022 ptos Increase Decrease In Management Fees Payables
IncreaseDecreaseInManagementFeesPayables
59734 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-54888 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24136 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
16629 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
20837 usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
18995 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
24517 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
25000 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
49000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22634 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45320 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31690 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-12976 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-565 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8208 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8208 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7644 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8208 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 ptos Goodwill Generated From Acquisition Of Subsidiary
GoodwillGeneratedFromAcquisitionOfSubsidiary
3168 usd
CY2022 ptos Goodwill Generated From Acquisition Of Subsidiary
GoodwillGeneratedFromAcquisitionOfSubsidiary
0 usd
CY2023 ptos Cancellation Of Stocks Subscription
CancellationOfStocksSubscription
0 usd
CY2022 ptos Cancellation Of Stocks Subscription
CancellationOfStocksSubscription
23897 usd
CY2022Q4 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
110000 usd
CY2022Q4 us-gaap Common Stock Convertible Conversion Price Increase
CommonStockConvertibleConversionPriceIncrease
0.03
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7961863 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-177528 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7644 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8208 usd
CY2023Q1 us-gaap Other Receivables
OtherReceivables
9263 usd
CY2022Q1 us-gaap Other Receivables
OtherReceivables
10940 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
219896 usd
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
225243 usd
CY2023Q1 us-gaap Goodwill
Goodwill
3168 usd
CY2023Q1 ptos Business Acquisitions Purchase Price Estimation
BusinessAcquisitionsPurchasePriceEstimation
0.25 pure
CY2023Q1 us-gaap Purchase Obligation
PurchaseObligation
0 usd
CY2023Q1 ptos Bank Consideration Paid
BankConsiderationPaid
6 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
6 usd
CY2023Q1 ptos Shareholder Loan Payable
ShareholderLoanPayable
-2196 usd
CY2023Q1 ptos Gst Payable During Acquisition
GstPayableDuringAcquisition
-977 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
3173 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
-3168 usd
CY2023Q1 us-gaap Goodwill
Goodwill
3168 usd
CY2023Q1 us-gaap Notes Payable
NotesPayable
544812 usd
CY2022Q1 us-gaap Notes Payable
NotesPayable
529344 usd
CY2023Q1 ptos Less Non Current Portion Of Promissory Note Payable
LessNonCurrentPortionOfPromissoryNotePayable
0 usd
CY2022Q1 ptos Less Non Current Portion Of Promissory Note Payable
LessNonCurrentPortionOfPromissoryNotePayable
0 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
544812 usd
CY2022Q1 us-gaap Notes Payable Current
NotesPayableCurrent
529344 usd
CY2023 us-gaap Notes Issued1
NotesIssued1
20000 usd
CY2023 us-gaap Debt Conversion Original Debt Interest Rate Of Debt
DebtConversionOriginalDebtInterestRateOfDebt
0.05 pure
CY2023 us-gaap Interest Expense
InterestExpense
32237 usd
CY2022 us-gaap Interest Expense
InterestExpense
30716 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
264482 usd
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
233064 usd
CY2023Q1 ptos Accrued Management Salary To Related Party
AccruedManagementSalaryToRelatedParty
635477 usd
CY2022Q1 ptos Accrued Management Salary To Related Party
AccruedManagementSalaryToRelatedParty
628290 usd
CY2023Q1 ptos Related Party Current Liabilities
RelatedPartyCurrentLiabilities
677962 usd
CY2022Q1 ptos Related Party Current Liabilities
RelatedPartyCurrentLiabilities
674426 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67946513 shares
CY2022Q1 ptos Common Stock Share Cancelled
CommonStockShareCancelled
2000000 shares
CY2022Q1 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
23897 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-177528 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-119838 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.26 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.26 pure
CY2023 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
46157 usd
CY2022 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
31158 usd
CY2023 ptos Valuation Allowance Change In Amount
ValuationAllowanceChangeInAmount
46157 usd
CY2022 ptos Valuation Allowance Change In Amount
ValuationAllowanceChangeInAmount
31158 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
2070084 usd
CY2022Q1 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
2023927 usd
CY2023 ptos Receive Deposit Against Goods
ReceiveDepositAgainstGoods
28694 usd

Files In Submission

Name View Source Status
0001640334-23-001477-index-headers.html Edgar Link pending
0001640334-23-001477-index.html Edgar Link pending
0001640334-23-001477.txt Edgar Link pending
0001640334-23-001477-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ptos-20230331.xsd Edgar Link pending
ptos_10k.htm Edgar Link pending
ptos_10kimg4.jpg Edgar Link pending
ptos_ex101.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ptos-20230331_def.xml Edgar Link unprocessable
ptos-20230331_lab.xml Edgar Link unprocessable
ptos-20230331_pre.xml Edgar Link unprocessable
ptos_10k_htm.xml Edgar Link completed
ptos_ex311.htm Edgar Link pending
ptos_ex312.htm Edgar Link pending
ptos_ex321.htm Edgar Link pending
ptos_ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ptos-20230331_cal.xml Edgar Link unprocessable